Ensysce Biosciences (ENSC) Net Long-Term Debt Issued (Repaid) (2020 - 2024)
Ensysce Biosciences' Non-Current Debt came in at $140,148 for Q4 2022, down 96.8% from $4.44 million a year earlier and down 90.1% from the prior quarter.
Powered by 
Analysis
Ensysce Biosciences (ENSC) Net Long-Term Debt Issued (Repaid) (2020 - 2024) Analysis & Trends
Going back to Q4 2019, Ensysce Biosciences' Non-Current Debt data covers 11 quarters.
- Non-Current Debt carries a three-year compound annual growth rate of -37.2% (FY2019 to FY2022).
- Going back by year, Non-Current Debt was $4.44 million in FY2021 (+684.2%), $566,288 in FY2020 (unchanged) and $566,288 in FY2019.
- The Q4 2022 figure represents the lowest quarterly Non-Current Debt in data going back to Q4 2019.
- Year-over-year, Non-Current Debt increased in two of the last four quarters, with growth averaging 206.9%.
- Business Quant data shows ENSC's Non-Current Debt at $1.41 million (Q3 2022), $360,797 (Q2 2022) and $1.59 million (Q1 2022) in the three quarters before Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net LT Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | -1.00 Mn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 9.98 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | -3.05 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | -19.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | - |
| 10 | Ensysce Biosciences | 901,219.67 | -10.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | -485,190.00 |
| Jun 30, 2023 | -584,857.00 |
| Mar 31, 2023 | -415,351.00 |
| Dec 31, 2022 | -1.14 Mn |
| Dec 31, 2021 | 9.48 Mn |
| Sep 30, 2021 | 4.50 Mn |
| Jun 30, 2021 | 50,000.00 |
| Mar 31, 2021 | 350,000.00 |
| Sep 30, 2020 | 300,000.00 |
| Jun 30, 2020 | -200,000.00 |
| Mar 31, 2020 | 1.00 Mn |
API Access
Ensysce Biosciences Net Long-Term Debt Issued (Repaid) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=ENSC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "ENSC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=ENSC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();